Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. HOOD
7. DFTX
8. GOOGL
9. MU
10. IBM

Go back to Alto Neuroscience Presents Phase 2a Data for ALTO-207 in Major Depressive Disorder at SOBP Annual Meeting
(NYSE: ANRO) Delayed: 22.93 +0.19 (0.84%)
Previous Close $22.74    52 Week High $ 
Open $23.09    52 Week Low $ 
Day High $23.95    P/E N/A 
Day Low $22.56    EPS $ 
Volume 366,747